ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board ...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...
It has been about a month since the last earnings report for Icon PLC (ICLR). Shares have lost about 9.7% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after ...
NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bleichmar Fonti & Auld LLP ("BFA") announces that it has filed a class action lawsuit for violations of the federal securities laws against ICON ...
ICON plc reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) of $3.26, surpassing the forecast of $3.19. This positive surprise, combined with revenue ...
ICON PLC (NASDAQ:ICLR) reported its Q3 2025 earnings, surpassing analysts’ expectations with an EPS of $3.31, slightly above the forecast of $3.30. Revenue also exceeded projections, reaching $2.043 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback